EUDA Health Limited (EUDA)
NASDAQ: EUDA
· Real-Time Price · USD
2.63
0.03 (1.15%)
At close: Aug 15, 2025, 12:28 PM
EUDA Health Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Oct 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.71M | 6.19M | 5.24M | 6.56M | 7.53M | 7.79M | 10.48M | 10.57M | 10.54M | 7.85M | 5.16M | 2.64M |
Cost of Revenue | 3.57M | 4.45M | 3.72M | 4.68M | 4.78M | 4.74M | 6.44M | 6.19M | 6.3M | 4.72M | 3.02M | 1.51M |
Gross Profit | 1.14M | 1.74M | 1.52M | 1.88M | 2.75M | 3.04M | 4.04M | 4.38M | 4.24M | 3.13M | 2.14M | 1.13M |
Operating Income | -20.38M | -20.74M | -12.87M | -12.04M | -10.55M | -2.24M | -1.99M | -753.4K | -279.61K | -53.97K | -8.38K | -7.85K |
Interest Income | n/a | n/a | n/a | n/a | n/a | 16.31K | 16.31K | 16.31K | 1.92M | 1.9M | 1.9M | 1.9M |
Pretax Income | -25.26M | -39.52M | -30.94M | -25.86M | -23.92M | -1.52M | -1.76M | -743.99K | -278.85K | -53.96K | -8.38K | -7.85K |
Net Income | -25.34M | -39.43M | -30.82M | -25.74M | -23.8M | -1.52M | -1.76M | -743.99K | -278.85K | -53.96K | -8.38K | -7.85K |
Selling & General & Admin | 6.63M | 9.76M | 9.04M | 9.22M | 8.03M | 4.11M | 3.85M | 1.46M | 279.6K | 53.96K | 8.38K | 7.85K |
Research & Development | 19.56K | 21.71K | 21.71K | 12.29K | 12.29K | 60.77K | 60.77K | 90.42K | 129.26K | 78.64K | 78.64K | 41.79K |
Other Expenses | 14.88M | 14.53M | 7.15M | 7.01M | 7.15M | 124.4K | 124.4K | 145.54K | n/a | n/a | n/a | n/a |
Operating Expenses | 21.52M | 36.49M | 28.4M | 27.27M | 25.38M | 2.24M | 1.99M | 753.39K | 279.6K | 53.96K | 8.38K | 7.85K |
Interest Expense | 18.76K | 102.92K | 102.92K | 107.54K | 116.25K | 32.09K | 32.09K | 20.09K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 566.03K | 1.31M | 1.29M | 1.45M | 1.41M | 948.88K | 1.24M | 1.28M | 1.26M | 960.36K | 666.28K | 343.43K |
Cost & Expenses | 25.09M | 40.95M | 32.12M | 30.19M | 26.99M | 2.24M | 1.99M | 753.39K | 279.6K | 53.96K | 8.38K | 7.85K |
Income Tax Expense | 1.84K | 58.45K | 57.97K | 150.22K | 155.06K | 99.67K | 99.67K | 47.62K | 54.36K | 52.65K | 52.65K | 12.57K |
Shares Outstanding (Basic) | 28.51M | 28.51M | 22.06M | 20.19M | 11.55M | 11.07M | 11.07M | 11.07M | 10.67M | 9.64M | 7.42M | 7.42M |
Shares Outstanding (Diluted) | 28.37M | 28.37M | 22.06M | 20.19M | 11.55M | 11.07M | 11.07M | 11.07M | 10.67M | 9.64M | 7.42M | 7.42M |
EPS (Basic) | -0.98 | -2.64 | -2.33 | -2.14 | -2.07 | -0.14 | -0.16 | -0.07 | -0.03 | -0.01 | -0.00 | -0.00 |
EPS (Diluted) | -1 | -2.65 | -2.33 | -2.14 | -2.07 | -0.14 | -0.16 | -0.07 | -0.03 | -0.01 | -0.00 | -0.00 |
EBITDA | -10.03M | -17.73M | -17.64M | -13.24M | -11.36M | -3.02M | -2.63M | -1.28M | -1.02M | -879.47K | -575.93K | -219.88K |
EBIT | -10.08M | -17.82M | -17.75M | -13.42M | -10.94M | -2.63M | -1.95M | -195.69K | -278.85K | -53.96K | -8.38K | -7.85K |
Depreciation & Amortization | -3.98M | -3.94M | -3.95M | 138.13K | 149.69K | 161.79K | 206.3K | 206.42K | 205.5K | 149.31K | 104.79K | 53.13K |